Price T Rowe Associates Inc Elevance Health, Inc. Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Elevance Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 5,838,911 shares of ELV stock, worth $1.9 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,838,911

Previous 8,085,205 27.78%

Holding current value

$1.9 Billion

Previous $3.14 Billion 40.01%

% of portfolio

0.2%

Previous 0.36%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$274.66 - $395.76 $617 Million - $889 Million	-2,246,294 Reduced 27.78%	5,838,911 $1.89 Billion
Q2 2025 Aug 14, 2025	SELL	$372.27 - $452.69 $394 Million - $479 Million	-1,057,358 Reduced 11.57%	8,085,205 $3.14 Billion
Q1 2025 May 14, 2025	SELL	$365.9 - $436.25 $540 Million - $644 Million	-1,475,499 Reduced 13.9%	9,142,563 $3.98 Billion
Q4 2024 Feb 14, 2025	BUY	$365.96 - $514.62 $170 Million - $239 Million	464,137 Added 4.57%	10,618,062 $3.92 Billion
Q3 2024 Nov 14, 2024	SELL	$500.12 - $562.29 $746 Million - $839 Million	-1,492,601 Reduced 12.82%	10,153,925 $5.28 Billion

Q2 2024 Aug 14, 2024	SELL	$497.49 - $547.8 $36.7 Million - $40.4 Million	-73,734 Reduced 0.63%	11,646,526 $6.31 Billion
Q1 2024 May 15, 2024	SELL	$464.61 - $519.96 $94.5 Million - $106 Million	-203,333 Reduced 1.71%	11,720,260 $6.08 Billion
Q4 2023 Feb 14, 2024	SELL	$433.51 - $488.06 $46.7 Million - $52.6 Million	-107,780 Reduced 0.9%	11,923,593 $5.62 Billion
Q3 2023 Nov 14, 2023	SELL	$414.13 - $475.93 $29.1 Million - $33.4 Million	-70,184 Reduced 0.58%	12,031,373 $5.24 Billion
Q2 2023 Aug 14, 2023	SELL	$436.33 - $496.2 $513 Million - $583 Million	-1,175,613 Reduced 8.85%	12,101,557 $5.38 Billion
Q1 2023 May 15, 2023	BUY	$446.3 - $502.2 $246 Million - $277 Million	551,614 Added 4.33%	13,277,170 $6.1 Billion
Q4 2022 Feb 14, 2023	BUY	$465.23 - $546.77 $921 Million - $1.08 Billion	1,979,665 Added 18.42%	12,725,556 $6.53 Billion
Q3 2022 Nov 14, 2022	BUY	$445.98 - $507.0 $575 Million - $654 Million	1,290,134 Added 13.64%	10,745,891 $4.88 Billion
Q2 2022 Aug 15, 2022	BUY	$444.32 - $529.84 $311 Million - $371 Million	699,906 Added 7.99%	9,455,757 $4.56 Billion
Q1 2022 May 16, 2022	SELL	$428.44 - $502.48 $449 Million - $526 Million	-1,047,018 Reduced 10.68%	8,755,851 $4.3 Billion
Q4 2021 Feb 14, 2022	SELL	$370.08 - $467.67 $7.61 Million - $9.61 Million	-20,557 Reduced 0.21%	9,802,869 $4.54 Billion
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $850 Million - $946 Million	-2,376,773 Reduced 19.48%	9,823,426 $3.66 Billion
Q2 2021 Aug 16, 2021	SELL	$352.19 - $401.9 $171 Million - $195 Million	-486,365 Reduced 3.83%	12,200,199 $4.66 Billion
Q1 2021 May 17, 2021	BUY	$287.7 - $371.31 $206 Million - $266 Million	715,968 Added 5.98%	12,686,564 $4.55 Billion
Q4 2020 Feb 16, 2021	BUY	$270.17 - $333.15 $3.23 Billion - $3.99 Billion	11,970,596 New	11,970,596 $3.84 Billion

Others Institutions Holding ELV

# of Institutions

1,782

Shares Held

199M

Call Options Held

2.38M

Put Options Held

2.17M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $78.2B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Elevance Health, Inc. Transaction History